Oncofetal ecosystems linked to recurrence and immunotherapy response in liver cancer

A team of clinician-scientists and researchers from the National Cancer Centre Singapore (NCCS), Agency for Science, Technology and Research (A*STAR), the Harry Perkins Institute of Medical Research and global research partners, has found a causal link between the presence of oncofetal ecosystems (re-emergence of fetal programme/features driven by the tumor) in the primary liver cancer hepatocellular carcinoma (HCC) and cancer recurrence and response to immunotherapy.

Novel Antiviral Shortens COVID Illness in Outpatients, Reduces Viral Load

With oral simnotrelvir/ritonavir treatment in a vaccinated population, COVID-19 symptoms went away about 1.5 days earlier and SARS-CoV-2 viral loads fell, a Chinese placebo-controlled phase

January 18, 2024

Do Our Flu Antivirals Work on H5N1?

With avian influenza A (H5N1) infecting more mammals than ever before — including U.S. dairy cattle — infectious disease experts are paying close attention to

May 1, 2024

Nkarta drops a cancer program, putting autoimmune front and center. Will it pay off?

Nkarta hit the brakes on one of its lead programs Thursday afternoon, deprioritizing a CAR-NK therapy designed to treat an aggressive form of leukemia after

March 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.